PEPTIC ULCER DISEASE
(By DR.S.UMA DEVI.M.D)
Introduction
A breach
in the lining of the upper GI tract in certain specific sites, caused by the
action of acid and pepsin.
Sites of occurance:
1.Duodenal
bulb(DU) first few inches of duodenum
2.
Stomach lesser curvature(Gastric ulcerGU)
Other
locations:
Esophagus
Pyloric
channel,
Duodenal
loop,
Jejunum
Meckles
diverticulum
Fig.1.Normal stomach
Pathogenesis
A
defect in the mucosa,submucosa and muscular layer of UGI tract
Normally
a balance exists between acid secretion and gastroduodenal mucosal defences
Here-Imbalance between Aggressive factors and
defensive factors in protecting normal gastric mucosa
Aggressive
factors:
1.Gastric
acid
2.Pepsin
3.Bile
acids
Defensive
factors
1.Gastric
mucosal barrier
2.Bicorbonates
3.Normal
mucosal blood flow
4.Ability
of nucosa to regenerate(cell restitution)
5. Gastric Mucus
Risk factors
Smoking
Heredity
Blood
group ‘O’and ‘A’
Imbalance
between aggressive and defensive hactors
results in peptic ulcer
1.On
aggressive side - Gastrinoma (Zollinger –Ellison syndrome)
2.On
defensive side -2 factors
A) NSAID
B)H.Pylori infection
These
external factors are not necessarily additive.
Etiology of ulcer
Commonest: Helicobactor .pylori
Next
common: NSAID induced
Less
common: hyper secretory state-Zollinger Ellison syndrome
(+ Gcell
hyperplasia,mastocytosis,basophilic
leukemias)
Present classification of ulcer disease:
(According
to true cause)
1.H.Pylori
related
2.NSAID
induced
3.
Related to Zollinger-Ellison syndrome.(Acid stimulating cancer)
Role
of acid in ulcer production
Acid
is fundamentally “causative” only in Zollinger Ellision syndrome
In
other 2 types though ‘not causative’ acid is essential permissive factor
(without
presence of acid, ulcer cannot develop in these 2)
|
Other
factors
Cigarette
smoking most important and worsening factor
Severe
physiological stress-Burns,CNS trauma,surgery,severe medical illness
Tobacco
chewing
Alcohol
excess
Process of Ulcer healing
1.Angiogenesis
of granulation tissue in the base of the ulcer
2.Replication
of epithelial cells at ulcer margin
3.Final
reestablish ment of glandular architecture
Clinical features
Age:
Peptic
ulcer common in younger age
Gastric
ulcer in old age
PUD
can also occur in children
Symptoms
The
most outstanding symptom-
epigastric
pain
Relived
by food /antacids
Severity
–variable-mild/moderate/severe
Nature-aching/burning
Location
generally epigastric
generally epigastric
But
may be high up under xiphisternum
Or
low down around umbilicus
DU
pain-typically-right epigastrium
GU
pain in left epigastrium(but overlap occurs)
If
pain radiates to back consider penetration
Typical
rhythm of the pain
Comes
after food and
eased
by antacids,vomiting or food
In
DU-
2hrs
after meals
In
GU-within ½ hr to 1hr after meals
In
DU-typical nocturnal pain inmiddle of night disturbing sleep.
Periodicity
Most
characteristic feature
Symptoms
last for a few days to weeks alternate with
periods
of remission Same or longer duration)
Relief
of pain with milk alkaliesD.D.gallstones or hyperacidity
Associated
symptoms:
Heartburn.
Waterbrash ,eructation’s ,vomiting
Vomiting
often relieves the pain
Apetitite
is usually good but patient is afraid
to eat.
Constipation
common
Loss
of weight common in GU .
Atypical
features
.1.No
pain but bouts of heartburn,waterbrash or vomiting
2.Hemetemesis;perforation(
early voluntary guarding or muscular rigidity)
3.Pain
may be totally unrelated to food
4.In
some –severe steady continuous pain+vomiting of highly acis gastric juice
5.Post
bubar duodenal ulcer: pain in the back and may be unrelated to food.
It
may manifest only with attacks of
intermittent vomiting /intermittent obstruction
6.Pyloric
channel ulcer:can cause obstruction,penetration and run accelerated course.
They
are difficult to treat medically.;periodicity ,rhythmicity absent
Pain
comes immeadiately after eating with
frequent vomiting.
Clinical
examination:
(History
is more important).
·
.tenderness in epigastrium on deep palpation
·
.Guarding or muscular rigidity over
ulcer
It signifies involvement of
peritoneum
·
Mass ;A tender mass may be palpable
When ulcer has leaked outside
·
Visible gastric peristalsis when there
is obstruction
·
Succusion splash may be heard after taking
fluid/food(gastric obstruction)
Complications;
·
Bleeding
·
Obstruction
·
Penetration causing pancreatitis
·
Perforation
·
Intractability
·
Frequent recurrences
Mortality causes: -
Bleeding
related:
Uncontrolled bleeding,during surgery for
bleeding,within 48 hrs after endoscopy,from surgical complications (within
1month),endoscopy related motality.
Non
bleeding related:
Cardiac,pulmonaruy
causes,CVD,multiorgan failure,malignancy related
Treatment for peptic ulcer -
Cure
of Helicobactor Pylori Infection
Avoidance
of NSAID
Appropriate
use of antisecretary therapy
Differential
Diagnosis:
Cholecystitis
Crohn’s
disease
Pancreatitis
Zollinger
–Ellison syndrome
Functional
dyspepsia
Gastritis
Duodenitis
Gastric
carcinoma
Investigations
Routine
lab tests specially anemia is alarm sign for early endoscopic study
Imaging study:
A double
contrast barium study by expert –
Can
accurately diagnose the ulcer
Test
for H.pylori-invasive and non invasive
Plain
xray chest in erect posture to diagnose perforation
Imaging
studies contra indicated in pregnancy
Disables
biopsy
Cannot
diagnose ulcers less than half centimeter.
Procedures
EGD-Esophago
–gastro- duodenoscopy
Advantage-
direct
visualistion,biopsy enabled,enables endoscopic therapy for bleeding ulcers
repeat endoscopy after 6 Wks to ensure healing
and to rule out malignancy
Brush
cytology to increase biopsy yield especially in the risk of bleeding (in
coagulopathy )
Urgent Indication for endoscopy
Those
presenting with alarm symptoms
Treatment options
Aim:
Healing
the ulcer
Curing
the ulcer diathesis
Medical
Empiric
antisecretary therapy
Empiric
triple therapy for H.pylori
Endoscopy and appropriate therapy based on findings
H.pylori
serology followed by triple therapy in
infected persons
Note : perform endoscopy early in patients >40-50 yrs
Surgical
care
Indications
Refractory cases
Refractory cases
Perforation
Obstruction(
Endoscopic balloon dilatation)
Massive
hemorrhage
Appropriate
surgical procedure:
Depends on nature and location
1.Simple
oversewing of ulcer with treatment for h.pylori/cessation of NSAID
2.
Vagotomy and pyloroplastywith
(Billroth
I -_Antrectomy with gastroduodenal reconstruction
Billroth
II- gastrojejunal reconstruction
Highly
selective vagotomy
Medications
For
h.pylori related PUD
Triple therapy PPI based
Consists of one
PPI+Amoxy +clarithromycin -14 days course
Replace amoxy with metronidazole
only in penicillin allergic cases-
because metronidzole resistance
is high.
For NSAID related-
cessation of NSAID
Appropriate course of PPI
In cases with known ulcer and if
NSAID are unavoidable-
Lowest possible dose and duration of NSAID and cotherapy with a PPI
and Misoprostol
List of PPIs (proton Pump inhibitors)
Omeprazole- 20mgPO-bid or
Rabeprazole- 20 mg-PO -bid
Lansoprazole-
30mgPO –bid/qd or
Esome-prazole-
40mg-PO qd
Action
of PPIs
Irreversibly
inhibit proton pump on parietal cell membrane
Proton
pump is an enzyme (H+/K+-ATPase)
This
enzyme actively secretes hydrogen ions into gastric lumen
Used
as capsules or enteric coated granules
Side
effects: diahrrea,skin rash, headache
Interaction
Only
omeprazole interacts with diazepam,phenytoin
&warfarin;not other PPIs
PPI
and antibiotics combination
is used in triple therapy
2
types therapy available
1.PPI
based (more commonly used)
2.Bismuth
based
Antibiotics
usable
Clarithromycin-500mg-PO-bid
(macrolide antibiotic)
Amoxicillin- 1gm PO-bid
Drugs used in quadriple therapy in case of
failure of triple therapy
Bismuth
525 mg-PO-qid
Metronidazole
500mg –Po-bid
Tetracycline- 500mg Po-qid
Cytoprotectants
Prostaglandin
analogue(in NSAID related PUD)
Prostaglandins
are weak inhibitors of gastric acid secretion
Prostaglandins
are cytoprotective
Misoprostol-200micro
gram PO-qid (Side effect uterine cramps)
Drugs
that do not directly inhibit acid production
Bismuth
salts
Mechanism
not known
But
heal H.pylori ulcers
Form
an insoluble protective layer over ulcer base
Thus
prevent damage by acid and pepsin
This
drug not recommended for long term or repeated use.
Sucralphate
(Sucrose
aluminium octasulphate)
Mechanism
of action not known
?
coats ulcer base ?stimulates local prostaglandin release.
H2 receptor blockers
Ranitidine 150mg-Po-bid
Famotidine 20mg PO-bid
Nizatidine 150mg Po-bid
(gastrin
stimulates parietal cells by releasing histamine
Follow
up
Minimum
healing time for ulcer is 8 wks
6-8
wks after initial diagnosis-
Endoscopy
–to confirm healing and to r/o malignancy
Documentation
of cure with non invasive tests for H.pylori
Inpatient
and outpatient Medication
For
recurrent/refractory/complicated ulcers:
Half
the standard dose of H2 receptor antagonist at bed time
When to
use prophylactic therapy?
Patients
requiring chronic NSAID therapy /NSAID induced ulcers
Patients
older than 60 yrs
Patients
with history of PUD or GI bleed
Patients
taking concomitant steroids/anti coagulants/or with severe comorbid conditions
Drugs
for prophylactic use
Misoprostol
100microgram PO 4 times per day
Omeprazole20
mg PO
daily once
Lansoprazole15mg
Po every day.
Antacids
Do
not effectively heal ulcer but relieve the symptoms of ulcer
Antacids
inter act with many drugs
Many
antacids contain a combination of magnesium and aluminium hydroxide
Aluminium
hydroxide-
Ill
effects-
constipation,
binds
with phosphates in the GI tract causing fall in blood phosphate(so weakness)
Magnesium
hydroxide
More
effective than ALOH
More
than 4 doses a day cause diahrroea
Antacid
must be used with caution in kidney disorder,heart disease and hypertension
Other
diseases Commonly associated:
Cirrohis,
renal failure,PT.
H.Pylori related Peptic ulcer
Helico bactor pylori
Introduction
1.Urase
producing organisms;spiral ;gram negative;
2.
colonises where there is gastric metaplasia
3.Found
in almost all cases of DU(2nd part part with gastric metaplasia)
4.In
70% of GU cases
5.Also
in normal persons;about 50% of worlds population is infected with H.Pylori
Infection
persists for many years.;leads to ulcer disease in 10-15% of people.
6.Always
associated with active chronic gastritis –histologically
7.
Spreads by feco-oral root through contaminated water.
8.
According to WHO- h.pylori is Type I carcinogen
9.
Causes gastritis/peptic ulcer/gastric carcinoma
10.The
spiral shape and flagella facilitates penetration into mucus layer and
attachment
to epithelial layer.
Discovery
of H.pylori has shown that peptic ulcer is a
simple infectious disease
Old dictim was : NO ACID No
ulcer
Present dictim : No H.Pylori No
Ulcer
Role in
ulcer pathogenesis:
·
On invading stomach releases toxins and enzymes injuring gastric
epithelium
·
Stomach and duodenal mucosa become
vulnerable to damage by aggressive factors
·
Thrives in alkaline medium so produces
urase which generates ammonia from urea
·
Ammonia+water=form free hydroxyl
radicles:free raicle disrupt epithelial integrity
·
Production of alkaline medium-enables
its survival in alkaline medium
·
Attracts nutrophils and
monocytes.,liberating interleukin and
TNF damaging gastric epithelium
·
Liberates proteinases and
phospholipases
·
These damage protective mucosal coat
exposing underlying epithelium for
damage
·
A cytotoxin associated gene(cagA) found often in this,is associated with
severity and carcinogenesis-gastric cancers and lymphoma
Diagnosis of H.pylori
Non
Invasive tests
1.Blood test : detects specific antibodies
to h.pylori ELISA test- best
2.Urea Breath test:-
Patien drinks
urea solution labeled with radio
active Carbon
that is broken down by H.Pylori
Hydrolysis
of urea------ produces labeled CO2
CO2
is rapidly absorbed in blood and appears in breath
Breath
test requires certain special prepations and indications
Unusable
in pregnancy
Accuracy
may be impaired by antibiotic and PPI use.
3.Stool
test: to detect H.pylori proteins in the stools
Non
invasive tests do not indicate if active infection is ongoing.
Antibodies
persist for long;so elisa test not useful to ascertain erradications
Invasive
tests:
Endoscopic biopsy with histological exam,culture and PCR
In
asymptomatic patients and in patients with no past history of PUD:
No
test required.
H.pylori
Treatment:
1.
Includes several medicines ( because
world wide bacterial resistance is a major
problem)
2.Two
medicines are antibiotics to kill the bacteria (Two to avoid antibiotic
resistance)
The
other medication is antisecretory which helps the ulcer to heal.
Most
are cured after finishing the course
Some
need a second course
Try
all medicine to ensure cure. Patient’s compliance is very important
Follow up: Ensure all bacteria are killed by follow up tests after tmt-breath or stool
test(4 wks after tmt)
Drug
regimen available: /
Principle involved :
Use
drugs
That kill the bacteria ,Reduce
stomach acid,andProtect stomach and duodenal lining
Medicines that reduce Stomach acid
·
PPIs
halts pumping of acid into stomach
·
H2 blockers –work by blocking histamine.
But PPIs have shown to
work better.
·
Bismuth sub salicylates coats ulcer and
protects from acid
(Though it might be
bacteriocidal,it is used with
antibiotics ,not in place of antibiotic)
In
Britain Clarithromycin based triple therapy (triple therapy in
short) is standard tmt.
Triple
therapy consists of (base on proton pump inhibitor)
1.
One PPI
2.
Clarithromycin
3.
Second
bacteriocidal Amoxycillin or
metronidazole
Duration of therapy- for 14 days (not 10 days- lesser cure
rates))
Quadriple
therapy
Used
in US.consists of (for 14 days)
1. PPI
2. Bismuth
subsalicylate
3. Tetracycline
4. metrnidazole
Situation in which used
Penicillin allergy
Resistance
to clarithromycin and
Failure
of triple therapy
Limitations – all regimens have. No single regimen of choice.
6
regimens were approved by FAD
|
I.
Dosing Schedules for All 3 Therapies
Dosing Schedule | LOAD (10 and 7 Day) | LAC (10 Day) |
Before breakfast | Omeprazole 40 mg | Lansoprazole 30 mg |
With breakfast | Levofloxacin 250 mg + nitazoxanide 500 mg | Amoxicillin 1000 mg + clarithromycin 500 mg |
With dinner | Nitazoxinide 500 mg + doxycycline 100 mg | Amoxicillin 1000 mg + clarithromycin 500 mg Treatment failure: |
Treatment failure
In
20% treatment failure occurs after first regimen(non compliance or drug
resistance)
A
second regimen is indicated in these
4weeks after completion of therapy, perform tests for persistence of
H.pylori
During
retreatment at least one of the antibiotic must be different from the one used before
Side
effects of regimen:
Nausea,dyspepsia,
metallic taste , head ache diahrrea,darkened stools.antabuse like effect.
Zollinger-Ellison syndrome(Gastrinoma)
Introduction
Adenoma/hyperplasia
of Islet cells of pancreas
Arise
from-multipotent endodermal stem cells
Excessive
gastrin secretion from tumor(Gastrinoma)
Result-excessive
stimulation of parietal cells to secrete acid
In
upper small intestine this hyperacidity
inactivates pancreatic lipase
+Bile
acids are precipitated-effect-steatorrhea,diahrrhea
Clinical features
Features
of peptic ulceration
Ulcers
–severe/multiple/
Ulcer
location-unusual-esophagus,jejunum
Intractable
recurrent ulceration occur following surgery for peptic ulcer
Bleeding
and perforation common
1/3rd
tumors malignant-spread to liver and
L.nodes
Multiple
endocrine hyperplasia in1/3rd (in pitutory,parathyroid,pancreas)
Investigations
Barium
meals-showing coarse gastric mucosal folds/ulcers
Endoscopy-shows
multiple ulcers at atypical sites
Abdominal
CT
Blood
levels of gastrin markedly raised>110pg/ml
Secretin
stimulation test
Investigations
for MENI (multiple endocrine neoplasia
Treatment
Surgical
removal of tumor if possible(single without regional nodes)
High
doses and long duration of Omeprazole therapy
Total
gastrectomy in unresponsive cases (rarely necessary these days)
Differences between gastric and duodenal ulcer
Gastric ulcer
|
Duodenal Ulcer
|
|
Age
|
More
than40 yrs
|
20-59
yrs
|
Sex
|
Equal
in both sexes
|
More
in males
|
Course
of illness
|
Less
remittant
|
More
remittent
|
Episodes
of pain
|
Relatively
longer in duration
|
Shorter
in durationRel
|
Antacids
|
Relief
of pain not consistent
|
Relief
prompt
|
food
|
Provokes
pain
|
Relieves
pain
|
heartburn
|
Less
common
|
More
common
|
Night
pain
|
Less
common
|
More
common
|
Anorexia,nausea
|
More
common
|
Less
common
|
Major types of Gastritis:
1.Erosive
gastritis
2.Non
erosive gastritis
Sub types
Superficial
gastritis
Atrophic
gastritis
Gastric
atrophy
Benign ulcers versus
malignant Gastric ulcers
Benign
Ulcers
|
Malignant
ulcer
|
|
1.CLINICAL
|
Age<40 o:p="" usually="">40>
|
Long
h/o yrs of duration
Remissions
and relapses a rule
Relief
of pain with food,vomiting
Loss
of appetite less common
Normal
or high acidity
Occult
blood rare ,transitory
Over40
yrs
Short
history
Not so
Not so
Loss
of appetite common
Anacidity
or low acidity
Frequent
and persists for long time
Site
of ulcer in images
Mostly
on vertical part of lesser curvature ;rare on
horizontal part
Crater
projects outside the margins of the stomach
Crater
smooth
Generally
on horizontal part or lesser curvature or on greater curvature
Crater
usually within the line of stomach
Crater
irregular,ragged
Endoscopy
Sharp
edge deep ulcer smooth base converging folds
Ill
defined edge,irregular floor with nodules in vicinity
************************
0 comments:
Post a Comment